Group design and comparative analysis Comparative safety profile: GLP-1 receptor agonist monotherapy versus combination therapy with metformin The pharmacovigilance analysis encompassed 262,355 adverse event (AE) reports associated with GLP-1 receptor agonist therapy
Most reactions are mild to moderate, but you should expect some level of joint or muscle discomfort especially in the first weeks
This includes patients with certain heart conditions or uncontrolled high blood pressure
GLP-1 medications can change how much you eat and drink, which may impact hydration levels
Out-of-pocket, scenario by scenario With commercial coverage of the indication and a savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps
Note this is not something you should do regularly, as it could increase the risk of side effects